Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection.

Lamarthée B, Delville M, Anglicheau D.

N Engl J Med. 2019 Aug 29;381(9):e16. doi: 10.1056/NEJMc1908072. No abstract available.

PMID:
31461604
2.

Sensitization to endothelial cell antigens: Unraveling the cause or effect paradox.

Jackson AM, Delville M, Lamarthée B, Anglicheau D.

Hum Immunol. 2019 Aug;80(8):614-620. doi: 10.1016/j.humimm.2019.04.014. Epub 2019 May 1. Review.

PMID:
31054781
3.

WITHDRAWN: [Non anti-HLA antibodies and acute rejection: A critical viewpoint].

Anglicheau D, Delville M, Lamarthee B.

Nephrol Ther. 2019 Apr;15 Suppl 1:S53-S59. doi: 10.1016/j.nephro.2019.03.003. French.

PMID:
30981396
4.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
5.

Quantitative and functional alterations of 6-sulfo LacNac dendritic cells in multiple myeloma.

Lamarthée B, de Vassoigne F, Malard F, Stocker N, Boussen I, Médiavilla C, Tang R, Fava F, Garderet L, Marjanovic Z, Brissot E, Mohty M, Gaugler B.

Oncoimmunology. 2018 Mar 19;7(7):e1444411. doi: 10.1080/2162402X.2018.1444411. eCollection 2018.

6.

LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.

Ceroi A, Masson D, Roggy A, Roumier C, Chagué C, Gauthier T, Philippe L, Lamarthée B, Angelot-Delettre F, Bonnefoy F, Perruche S, Biichle S, Preudhomme C, Macintyre E, Lagrost L, Garnache-Ottou F, Saas P.

Blood. 2016 Dec 8;128(23):2694-2707. Epub 2016 Oct 4.

7.

Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.

Lamarthée B, Malard F, Saas P, Mohty M, Gaugler B.

Front Immunol. 2016 Apr 19;7:148. doi: 10.3389/fimmu.2016.00148. eCollection 2016. Review.

8.

Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.

Malard F, Gaugler B, Lamarthee B, Mohty M.

Mucosal Immunol. 2016 Mar;9(2):299-308. doi: 10.1038/mi.2015.143. Epub 2016 Jan 27. Review.

PMID:
26813345
9.

Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10.

Lamarthée B, Malard F, Gamonet C, Bossard C, Couturier M, Renauld JC, Mohty M, Saas P, Gaugler B.

Mucosal Immunol. 2016 Mar;9(2):309-21. doi: 10.1038/mi.2015.61. Epub 2015 Jul 8.

PMID:
26153763
10.

Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease.

Arbez J, Saas P, Lamarthée B, Malard F, Couturier M, Mohty M, Gaugler B.

Cytotherapy. 2015 Jul;17(7):948-55. doi: 10.1016/j.jcyt.2015.02.009. Epub 2015 Mar 23.

PMID:
25813681
11.

Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.

Janikashvili N, Trad M, Gautheron A, Samson M, Lamarthée B, Bonnefoy F, Lemaire-Ewing S, Ciudad M, Rekhviashvili K, Seaphanh F, Gaugler B, Perruche S, Bateman A, Martin L, Audia S, Saas P, Larmonier N, Bonnotte B.

J Allergy Clin Immunol. 2015 Jun;135(6):1614-24.e4. doi: 10.1016/j.jaci.2014.12.1868. Epub 2015 Jan 25.

PMID:
25630940
12.

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

Angelot-Delettre F, Roggy A, Frankel AE, Lamarthee B, Seilles E, Biichle S, Royer B, Deconinck E, Rowinsky EK, Brooks C, Bardet V, Benet B, Bennani H, Benseddik Z, Debliquis A, Lusina D, Roussel M, Solly F, Ticchioni M, Saas P, Garnache-Ottou F.

Haematologica. 2015 Feb;100(2):223-30. doi: 10.3324/haematol.2014.111740. Epub 2014 Nov 7.

13.

Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function.

Arbez J, Lamarthée B, Gaugler B, Saas P.

Immunobiology. 2014 Aug;219(8):637-43. doi: 10.1016/j.imbio.2014.03.013. Epub 2014 Mar 29.

PMID:
24742998
14.

[Interleukin-22: its role in graft-versus-host-disease unraveled].

Gaugler B, Lamarthée B, Couturier M, Saas P.

Med Sci (Paris). 2013 Jun-Jul;29(6-7):577-9. doi: 10.1051/medsci/2013296008. Epub 2013 Jul 12. French. No abstract available.

15.

IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.

Couturier M, Lamarthée B, Arbez J, Renauld JC, Bossard C, Malard F, Bonnefoy F, Mohty M, Perruche S, Tiberghien P, Saas P, Gaugler B.

Leukemia. 2013 Jul;27(7):1527-37. doi: 10.1038/leu.2013.39. Epub 2013 Feb 12.

PMID:
23399894

Supplemental Content

Loading ...
Support Center